argenx SE
General ticker "ARGNF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.2B (TTM average)
argenx SE follows the US Stock Market performance with the rate: 32.5%.
Estimated limits based on current volatility of 0.1%: low 898.39$, high 900.89$
Short-term ARGNF quotes
Long-term ARGNF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,226.32MM | $2,248.20MM | $4,320.27MM |
| Operating Expenses | $1,651.37MM | $2,269.86MM | $3,311.35MM |
| Operating Income | $-425.05MM | $-21.65MM | $1,008.92MM |
| Non-Operating Income | $120.55MM | $106.83MM | $321.73MM |
| Interest Expense | $0.90MM | $2.46MM | $4.25MM |
| R&D Expense | $859.49MM | $949.30MM | $1,419.65MM |
| Income(Loss) | $-304.50MM | $85.18MM | $1,330.65MM |
| Taxes | $-9.44MM | $-747.86MM | $-13.97MM |
| Net Income(Loss)* | $-165.06MM | $1,687.73MM | $1,344.62MM |
| Stockholders Equity | $4,097.51MM | $5,498.28MM | $7,323.47MM |
| Inventory | $310.55MM | $407.23MM | $473.55MM |
| Assets | $4,542.46MM | $6,202.52MM | $8,683.14MM |
| Operating Cash Flow | $-420.33MM | $-82.75MM | $882.37MM |
| Capital expenditure | $43.81MM | $1.80MM | $6.42MM |
| Investing Cash Flow | $308.21MM | $-717.59MM | $854.76MM |
| Financing Cash Flow | $1,336.73MM | $279.76MM | $242.49MM |
| Earnings Per Share** | $-2.89 | $28.20 | $21.94 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.